Illumina (ILMN) EBITDA Margin (2009 - 2026)

Illumina (ILMN) has reported EBITDA Margin for 18 consecutive years, with 21.14% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 93.0% year-over-year to 21.14%; the trailing twelve-month figure through Jun 2026 stood at 19.63% (down 1057.0% YoY), and the FY2025 full-year result was 18.58%, up 3763.0% from the prior year.
• EBITDA Margin grew to 21.14% in Q2 2026 per ILMN's latest filing, from 19.16% in the prior quarter.
• Across five years, EBITDA Margin topped out at 68.61% in Q3 2024 and bottomed at 327.98% in Q4 2022.
• Historically, EBITDA Margin has averaged 40.89% across 5 years, with a median of 4.58% in 2022.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 27879 bps in 2022, then surged 30479 bps in 2023.
• Over 5 years, EBITDA Margin stood at 327.98% in 2022, then soared by 96 bps to 14.62% in 2023, then surged by 208 bps to 15.85% in 2024, then increased by 9 bps to 17.34% in 2025, then gained by 22 bps to 21.14% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 21.14%, 19.16%, and 17.34% for Q2 2026, Q1 2026, and Q4 2025 respectively.